Lee‐Jen Wei

686 total citations
22 papers, 470 citations indexed

About

Lee‐Jen Wei is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Statistics and Probability. According to data from OpenAlex, Lee‐Jen Wei has authored 22 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Oncology and 4 papers in Statistics and Probability. Recurrent topics in Lee‐Jen Wei's work include Blood Pressure and Hypertension Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Lee‐Jen Wei is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Lee‐Jen Wei collaborates with scholars based in United States, China and United Kingdom. Lee‐Jen Wei's co-authors include Guosheng Yin, Zachary R. McCaw, Elaine H. Mischler, Michael J. Rock, David J. Hassemer, W. Theodore Bruns, Philip M. Farrell, Ronald H. Laessig, Alan J. Tuchman and David Crockford and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lee‐Jen Wei

20 papers receiving 455 citations

Peers

Lee‐Jen Wei
Ulrika Wählby Sweden
Jae Eun Ahn United States
K. F. Cheng Taiwan
Joakim Nyberg Sweden
Mindy Magee United States
Kenneth G. Kowalski United States
Aditi Shendre United States
Teun M. Post Netherlands
Sandrine Micallef France
Aubrey Stoch United States
Ulrika Wählby Sweden
Lee‐Jen Wei
Citations per year, relative to Lee‐Jen Wei Lee‐Jen Wei (= 1×) peers Ulrika Wählby

Countries citing papers authored by Lee‐Jen Wei

Since Specialization
Citations

This map shows the geographic impact of Lee‐Jen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee‐Jen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee‐Jen Wei more than expected).

Fields of papers citing papers by Lee‐Jen Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee‐Jen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee‐Jen Wei. The network helps show where Lee‐Jen Wei may publish in the future.

Co-authorship network of co-authors of Lee‐Jen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lee‐Jen Wei. A scholar is included among the top collaborators of Lee‐Jen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee‐Jen Wei. Lee‐Jen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flitter, Becca A., Joshua Gillard, Marcela F. Pasetti, et al.. (2025). An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study. Science Translational Medicine. 17(798). eadh9906–eadh9906. 2 indexed citations
2.
3.
Pawlyn, Charlotte, Fredrik Schjesvold, David A. Cairns, et al.. (2024). Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood Cancer Journal. 14(1). 134–134. 4 indexed citations
4.
Shi, Sandra, Natalia Gouskova, Chan Mi Park, et al.. (2023). Balancing Benefit and Harm of Intensive Blood Pressure Lowering Based on Individual Outcome Profile Analysis. The American Journal of Medicine. 136(12). 1196–1202.e2.
5.
Kim, Dae Hyun, Curtis Tatsuoka, Zhengyi Chen, et al.. (2022). Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial. Journal of General Internal Medicine. 37(15). 3797–3804. 1 indexed citations
6.
Shi, Sandra, Natalia Gouskova, Mehdi Najafzadeh, Lee‐Jen Wei, & Dae Hyun Kim. (2021). Intensive versus standard blood pressure control in type 2 diabetes: a restricted mean survival time analysis of a randomised controlled trial. BMJ Open. 11(9). e050335–e050335. 8 indexed citations
7.
Kim, Dae Hyun, et al.. (2021). Restricted mean survival time versus conventional measures for treatment decision‐making. Journal of the American Geriatrics Society. 69(8). 2282–2289. 4 indexed citations
8.
Kim, Dae Hyun, et al.. (2021). Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia. JAMA Network Open. 4(1). e2034745–e2034745. 4 indexed citations
9.
Richardson, Paul G., Sundar Jagannath, Ajai Chari, et al.. (2020). Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma. SHILAP Revista de lepidopterología. 2(1). 48–55. 8 indexed citations
10.
McDonald, Craig M., Lee‐Jen Wei, Gary Elfring, et al.. (2019). Preservation of Function over time as Measured by North Star Ambulatory Assessment in Ambulatory Boys with Nonsense Mutation Muscular Dystrophy Treated with Ataluren (S51.004). Neurology. 92(15_supplement). 1 indexed citations
11.
Farlow, Martin R., Richard E. Thompson, Lee‐Jen Wei, et al.. (2018). A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease. Journal of Alzheimer s Disease. 67(2). 555–570. 63 indexed citations
12.
Palumbo, Paul, Jane C. Lindsey, Moherndran Archary, et al.. (2017). Defining Study Outcomes That Better Reflect Individual Response to Treatment. The Pediatric Infectious Disease Journal. 37(3). 258–262. 1 indexed citations
13.
Elkayam, Uri, Munir Janmohamed, Parta Hatamizadeh, et al.. (2009). Impact of Acute Serum Creatinine Elevation in Patients Treated with Nesiritide. Clinical Cardiology. 32(4). 215–219. 1 indexed citations
14.
Dienstag, Jules L., Lee‐Jen Wei, Dong Xu, & Bruce Kreter. (2007). Cross-Study Analysis of the Relative Efficacies of Oral Antiviral Therapies for Chronic Hepatitis B Infection in Nucleoside-Naive Patients. Clinical Drug Investigation. 27(1). 35–49. 19 indexed citations
15.
Feng, Yan, Xiumei Hong, Zhiping Li, et al.. (2006). Prevalence of Metabolic Syndrome and Its Relation to Body Composition in a Chinese Rural Population. Obesity. 14(11). 2089–2098. 63 indexed citations
16.
Eshleman, Susan H., Paul Krogstad, J. Brooks Jackson, et al.. (2001). Analysis of Human Immunodeficiency Virus Type 1 Drug Resistance in Children Receiving Nucleoside Analogue Reverse‐Transcriptase Inhibitors plus Nevirapine, Nelfinavir, or Ritonavir (Pediatric AIDS Clinical Trials Group 377). The Journal of Infectious Diseases. 183(12). 1732–1738. 38 indexed citations
17.
Xu, Xin, Lyle J. Palmer, Steve Horvath, & Lee‐Jen Wei. (2001). Combining Multiple Phenotypic Traits Optimally for Detecting Linkage with Sib‐Pair Observations. Genetic Epidemiology. 21(S1). S479–83. 3 indexed citations
18.
Wei, Lee‐Jen, et al.. (1999). Issues in genomic screening: Critical values, sample sizes, and the ability to detect linkage. Genetic Epidemiology. 17(S1). S697–701. 1 indexed citations
19.
Wei, Lee‐Jen, et al.. (1994). Confidence bands for survival curves under the proportional: Hazards model. Biometrika. 81(1). 73–81. 116 indexed citations
20.
Rock, Michael J., Elaine H. Mischler, Philip M. Farrell, et al.. (1990). Newborn Screening for Cystic Fibrosis Is Complicated by Age-Related Decline in Immunoreactive Trypsinogen Levels. PEDIATRICS. 85(6). 1001–1007. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrika Wählby Breakdown of academic impact, for papers by Jae Eun Ahn Breakdown of academic impact, for papers by K. F. Cheng Breakdown of academic impact, for papers by Joakim Nyberg Breakdown of academic impact, for papers by Mindy Magee Breakdown of academic impact, for papers by Kenneth G. Kowalski Breakdown of academic impact, for papers by Aditi Shendre Breakdown of academic impact, for papers by Teun M. Post Breakdown of academic impact, for papers by Sandrine Micallef Breakdown of academic impact, for papers by Aubrey Stoch
Rankless by CCL
2026